KFF Health News March 21, 2024
Michael Scaturro

Online stores sprang up during the covid-19 pandemic’s telehealth boom touting testosterone as a cure-all for men’s age-related illnesses — despite FDA rules issued years ago restricting such “low testosterone” advertising.

In ads on Google, Facebook, and elsewhere, testosterone telemedicine websites may promise a quick fix for sluggishness and low libido in men. But evidence for that is lacking, physicians said, and the midlife malaise for which testosterone is being touted as a solution is more likely caused by chronic medical conditions, poor diet, or a sedentary lifestyle. In fact, doctors urge caution — and the FDA recommends that all testosterone supplements carry a warning that they may increase the risk of heart attack and stroke.

Valid medical reasons do...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, FDA, Govt Agencies, Patient / Consumer, Provider, Technology, Telehealth
Telehealth Takes Center Stage With ATA Nexus
ATA Meeting Showcases Telehealth's Changing Landscape
House reps introduce bills to make telehealth flexibilities permanent
Opinion: Virtual first is flaming out. A virtual-second model can refresh telehealth
Telehealth, hybrid care adding to physicians' EHR workload

Share This Article